Stereoselective pharmacokinetics of atenolol in the rat: influence of aging and of renal failure. 1993

F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
Heymans Institute of Pharmacology, University of Gent Medical School, Belgium.

The pharmacokinetics of R- and S-atenolol after intravenous administration of racemic atenolol were studied in 3-, 12- and 24-month-old rats and in 3-month-old rats with renal failure induced by uranyl nitrate. In all age groups, the area under the plasma concentration-time curves is higher for R- than for S-atenolol; volume of distribution, total clearance and renal clearance are lower for R-atenolol than for S-atenolol, but the differences are small. In function of age there is for both enantiomers a significant increase in AUC, due, at least in part, to a decreased renal clearance; the effect of aging is not stereoselective. In rats with renal failure, the AUC of both enantiomers increases, due mainly to a decrease in renal clearance, but to a lesser degree also to a decrease in nonrenal clearance. For both enantiomers, the volume of distribution decreases and the half-life increases in the uraemic rats. The total amount of both enantiomers excreted in the urine is decreased in the rats with renal failure. There are no stereoselective effects of treatment of the rats with uranyl nitrate.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014502 Uranyl Nitrate Bis(nitrato-O)dioxouranium. A compound used in photography and the porcelain industry. It causes severe renal insufficiency and renal tubular necrosis in mammals and is an effective lymphocyte mitogen. Uranium Nitrate,Nitrate, Uranium,Nitrate, Uranyl

Related Publications

F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
January 1992, Chirality,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
April 1980, British journal of clinical pharmacology,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
August 1995, Journal of clinical pharmacology,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
September 1980, Clinical pharmacology and therapeutics,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
November 1977, European journal of clinical pharmacology,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
January 1981, European journal of clinical pharmacology,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
September 1990, British journal of clinical pharmacology,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
April 1979, British journal of clinical pharmacology,
F M Belpaire, and M T Rosseel, and A M Vermeulen, and F De Smet, and M G Bogaert
February 1998, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!